Enhancing the Accuracy of Platelet to Lymphocyte Ratio after Adjustment for Large Platelet Count: A Pilot Study in Breast Cancer Patients

Table 1

Display and comparison of the evaluated parameters of our study sample.

Mean values	Group A	Group B	Group C	𝑃 value
	(fibroadenomas)	(grade II IDC)	(grade III IDC)
Age (years)	45.5 (23–73)	55.29 (40–85)	65.39 (39–74)	<0.001
PLR (%)	137.94 (57.7–354.17)	145.48 (83.3–206.25)	160.15 (95.5–330.83)	0.558
Platelet-large cell ratio (%)	30.87 (18.7–47.2)	33.02 (24–50.2)	35.76 (26.3–49.5)	0.091
LPLR (%)	40.88 (20.38–81.1)	44.27 (31.35–72)	55.91 (38.66–87.77)	0.005
NLR (%)	1.77 (0.64–3.31)	2.27 (1.43–4.07)	2.68 (1.64–4.08)	<0.001
d-dimers (ng/mL)	288.22 (176.9–694.3)	586.4 (170.2–870.08)	650.68 (170.2–965.3)	<0.001